US and Europe Cell and Gene Therapy Manufacturing Services Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. US and Europe Cell and Gene Therapy Manufacturing Services Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. US and Europe Cell and Gene Therapy Manufacturing Services Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. US and Europe Cell and Gene Therapy Manufacturing Services Market Regional Analysis

6.2 US and Europe Cell and Gene Therapy Manufacturing Services Market Revenue 2020-2030 (US$ Million)

6.3 US and Europe Cell and Gene Therapy Manufacturing Services Market Forecast Analysis

7. US and Europe Cell and Gene Therapy Manufacturing Services Market Analysis – by Type

7.1 Allogenic

7.1.1 Overview
7.1.2 Allogenic: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Autologous

7.2.1 Overview
7.2.2 Autologous: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.3 Viral Vector

7.3.1 Overview
7.3.2 Viral Vector: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.4 Non-Viral Vector

7.4.1 Overview
7.4.2 Non-Viral Vector: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. US and Europe Cell and Gene Therapy Manufacturing Services Market Analysis – by Indication

8.1 Cancer

8.1.1 Overview
8.1.2 Cancer: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Orthopedics

8.2.1 Overview
8.2.2 Orthopedics: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. US and Europe Cell and Gene Therapy Manufacturing Services Market Analysis – by Application

9.1 Clinical Manufacturing and Commercial Manufacturing

9.1.1 Overview
9.1.2 Clinical Manufacturing and Commercial Manufacturing: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. US and Europe Cell and Gene Therapy Manufacturing Services Market Analysis – by End User

10.1 Pharmaceutical and Biotechnology Companies and Contract Research Organizations

10.1.1 Overview
10.1.2 Pharmaceutical and Biotechnology Companies and Contract Research Organizations: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. US and Europe Cell and Gene Therapy Manufacturing Services Market – United State Analysis

11.1 Overview

11.2 Asia-Pacific

11.2.1 US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast Analysis – by Country
11.2.1.1 China: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 China: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
11.2.1.1.2 China: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
11.2.1.1.3 China: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
11.2.1.1.4 China: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by End User

11.2.1.2 India: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 India: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
11.2.1.2.2 India: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
11.2.1.2.3 India: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
11.2.1.2.4 India: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by End User

11.2.1.3 Japan: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 Japan: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
11.2.1.3.2 Japan: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
11.2.1.3.3 Japan: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
11.2.1.3.4 Japan: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by End User

11.2.1.4 Australia: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.4.1 Australia: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
11.2.1.4.2 Australia: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
11.2.1.4.3 Australia: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
11.2.1.4.4 Australia: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by End User

11.2.1.5 Rest of Asia-Pacific : US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.5.1 Rest of Asia-Pacific : US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
11.2.1.5.2 Rest of Asia-Pacific : US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
11.2.1.5.3 Rest of Asia-Pacific : US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
11.2.1.5.4 Rest of Asia-Pacific : US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by End User

11.3 United State

11.3.1 US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Key Country, 2023 and 2030 (%)
11.3.1.1 US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast Analysis – by Country
11.3.1.1 United State: US and Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.3.1.1.1 United State: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
11.3.1.1.2 United State: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
11.3.1.1.3 United State: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
11.3.1.1.4 United State: US and Europe Cell and Gene Therapy Manufacturing Services Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Thermo Fisher Scientific Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Merck KGaA

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Charles River Laboratories International Inc

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Lonza Group AG

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 WuXi AppTec Co Ltd

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Catalent Inc

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Takara Bio Inc

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Nikon Corp

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 FUJIFILM Holdings Corp

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 National Resilience Inc,

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 OxfordBioMedica Plc

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

US and Europe Cell and Gene Therapy Manufacturing Services Market